Skip to content

Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Male and Female Rats.

Alexa Torrens, Pritam Roy, Lin Lin, Cindy Vu, Dakota Grimes, Victoria C Inshishian, Johanna S Montesinos, Faizy Ahmed, Stephen V Mahler, Marylin A Huestis, Aditi Das, Daniele Piomelli

Cannabis and Cannabinoid Research December 2022 DOI: 10.1089/can.2021.0205 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Comparative pharmacokinetic study in rats Peer reviewed
Population Adolescent (33-day-old acute; 30–44-day-old subchronic) and young adult (70-day-old acute) male and female laboratory rats
Dose 0.5 or 5 mg/kg (acute); 5 mg/kg (subchronic), intraperitoneal
Duration Single acute administration or 2-week daily subchronic administration
Measures isotope-dilution liquid chromatography/tandem mass spectrometry assay (plasma and brain THC, 11-OH-THC, 11-COOH-THC), body temperature via abdominally implanted microchips, liver microsome biotransformation assay
Topics Cannabis
Keywords Pharmacokinetics Δ9-tetrahydrocannabinol
Key points The authors report multiple age and sex differences in THC distribution and metabolism in rats: adult plasma THC peaked twice as high as in adolescents, but adult brain-to-plasma ratios were 25–50% lower; 11-OH-THC was two- to sevenfold higher in females than males; and adolescent and female liver microsomes converted THC to 11-OH-THC twice as fast as adult male microsomes. Subchronic adolescent THC did not significantly alter the PK profile.

Abstract

Introduction: Studies in rodent models have shown that adolescent exposure to Δ9-THC, the psychotropic constituent of cannabis, produces long-lasting alterations in brain function and behavior. However, our understanding of how age and sex might influence the distribution and metabolism of THC in laboratory rodents is still incomplete. In the present report, we provide a comparative analysis of the pharmacokinetic (PK) properties of THC in adolescent and adult rats of both sexes, and outline several dissimilarities across these groups.

Materials and Methods: A single (acute) or 2-week daily (subchronic) administration of THC (0.5 or 5 mg/kg, acute; 5 mg/kg, subchronic; intraperitoneal) was given to adolescent (33-day-old, acute; 30-44-day-old, subchronic) and young adult (70-day-old, acute only) male and female rats. THC and its first-pass metabolites-11-hydroxy-Δ9-THC (11-OH-THC) and 11-nor-9-carboxy-Δ9-THC (11-COOH-THC)-were quantified in plasma and brain tissue using a selective isotope-dilution liquid chromatography/tandem mass spectrometry assay. Changes in body temperature were measured using abdominally implanted microchips. Biotransformation of THC to its metabolites using freshly prepared liver microsomes was assessed.

Results: At the acute 5 mg/kg dose, maximal plasma concentrations of THC were twice as high in adult than in adolescent rats. Conversely, in adults, brain concentrations and brain-to-plasma ratios for THC were substantially lower (25-50%) than those measured in adolescents. Similarly, plasma and brain concentrations of THC metabolites were higher in adolescent male rats compared with adult males. Interestingly, plasma and brain concentrations of the psychoactive THC metabolite 11-OH-THC were twofold to sevenfold higher in female animals of both ages compared with males. Moreover, liver microsomes from adolescent males and adolescent and adult females converted THC to 11-OH-THC twice as fast as adult male microsomes. A dose-dependent hypothermic response to THC was observed in females with 0.5 and 5 mg/kg THC, whereas only the highest dose elicited a response in males. Finally, subchronic administration of THC during adolescence did not significantly affect the drug's PK profile.

Conclusions: The results reveal the existence of multiple age and sex differences in the distribution and metabolism of THC in rats, which might influence the pharmacological response to the drug.

Comparable studies

Other preclinical and animal studies on cannabis, most cited first.

Study Year Design Participants
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors Mice 2015 Preclinical study
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). hMDR1- and hBCRP-transfected HEK293 cells and hMDR1- and hBCRP-MDCKII cells 2010 In vitro study
Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure Mice prenatally exposed to THC, including conditional CB1R knockout mice 2020 Animal experimental study
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway Mice exposed to chronic THC early in life 2018 Animal experimental study
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain Spontaneously hypertensive rats (SHRs) and Wistar rats 2014 Animal experimental study

Citations in the library

Explore topics